1. Vanbellinghen MC, van der Wulp IAJ, Postema PG, Kors JA, et al.
   Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV.
   AIDS 2026.
   


2. Niu Y, Li N, Shi X, Jia X, et al.
   Time-dependent mortality effects of dynamic antiretroviral therapy regimens.
   AIDS 2026.
   


3. Ma J, Ruderman SA, Haidar L, Delaney JA, et al.
   Impact of semaglutide on liver fibrosis score in people with HIV: findings from the CNICS cohort.
   AIDS 2026.
   


4. Campbell JI, Vachharajani O, Dubois MM, Martinez L, et al.
   Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis.
   AIDS 2026.
   


5. Chihota V, Waggie Z, Cardenas V, Mngadi K, et al.
   Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.
   Clin Infect Dis 2026.
   


6. Hazra A, Chan PA, Clement M, Kaperak CJ, et al.
   Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.
   Clin Infect Dis 2026.
   


7. Beach R, Tims-Cook Z, McGary CS, Thote T, et al.
   Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists.
   Clin Infect Dis 2026;82:S87-S91.
   


8. Parienti JJ, Yang SS, Grinspoon S.
   Selected Industry Highlights From IDWeek 2025.
   Clin Infect Dis 2026;82:S85-S86.
   


9. Spinelli MA, Ewart LD, Ross EJ, Heise MJ, et al.
   Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-term PrEP Adherence for U.S. MSM in Pilot RCT.
   Clin Infect Dis 2026.
   


10. Kintu TM, Nnyombi M, Kihumuro RB, Kanyike AM, et al.
    Beyond Testing: Exploring the Psychosocial Impact of HIV Self-Testing among Ugandan Gender-Diverse Sex Workers.
    J Acquir Immune Defic Syndr 2026.
    


11. Erly S, Yan H, Kerani RP, Mei Y, et al.
    Evaluating Time-Space Methodologies to Detect Clusters of HIV Transmission: a Comparison of Advanced Methods in Washington State, 2010-2022.
    J Acquir Immune Defic Syndr 2026.
    


12. Sophus AI, Mitchell JW, Fuentes JF, Collins S, et al.
    Preferences for PrEP program attributes among Black women across the Southern United States: A discrete choice experiment.
    J Acquir Immune Defic Syndr 2026.
    


13. Traeger MW, Leyden WA, Eberhart LG, Volk JE, et al.
    Long-acting injectable cabotegravir HIV PrEP uptake, adherence, and persistence in two large US integrated healthcare systems.
    J Acquir Immune Defic Syndr 2026.
    


14. Kasirye R, Yang P, White JL, Tassiopoulos K, et al.
    Hospitalization rates and associated factors among older adults with HIV in the US.
    J Acquir Immune Defic Syndr 2026.
    


15. van der Merwe FH, Dreyer G, Visser C, Dreyer GJ, et al.
    Extended Genotyping as Triage of HPV Positive Screened Women in Low-and-Middle Income Countries.
    J Med Virol 2026;98:e70981.
    


16. Laxminarayan R, Limmathurotsakul D, de Abreu AL, Alimi Y, et al.
    Meeting the 2024 UN General Assembly declaration targets on antimicrobial resistance.
    Lancet 2026.
    


17. Luque MT, Du L, Rouzier V, Machado DM, et al.
    Use of Integrase Strand Transfer Inhibitors Among Children Living With HIV in Latin America and the Caribbean.
    Pediatr Infect Dis J 2026.
    


18. Rubio-Duarte AF, Garces-Rodriguez MP, Hurtado-Ortiz A, Forero-Manzano MJ, et al.
    Severe Pneumocystis jirovecii Pneumonia as the Sentinel Presentation of BENTA Disease: Case Report of a 3-month-old Infant.
    Pediatr Infect Dis J 2026.
    

Display articles in

• Abstract format